Trends in clinical presentation and treatment outcomes in a South African TTP cohort

dc.contributor.advisorVerburgh, Estelle
dc.contributor.advisorBailly, Jenique
dc.contributor.authorVundla, Nokubonga
dc.date.accessioned2024-11-01T13:20:58Z
dc.date.available2024-11-01T13:20:58Z
dc.date.issued2024
dc.date.updated2024-07-09T13:26:20Z
dc.description.abstractBackground: HIV is the most common cause of secondary thrombotic thrombocytopenic purpura (TTP) in South Africa. Objectives: To assess the clinical presentations and outcomes of patients treated for HIV-associated and idiopathic TTP. Methods: We conducted a retrospective cohort study of patients consecutively diagnosed with TTP from 2010 to 2020 at Groote Schuur Hospital. Study participants were identified by reviewing patient files and Western Cape Blood Services records. Kaplan-Meier curves and log-rank tests were used to evaluate remission rates overall and, by HIV status and treatment group. Logistic regression models were used to identify predictors of remission and relapse. Results: 139 patients were included, 85.6% of whom were HIV positive. There were no significant differences in the TTP pentad features by HIV status. Most patients achieved remission (71.9%) with an overall median time of 8 days. Remission occurred significantly earlier in those treated with FFPs only, suggesting less severe disease (median=8 days [IQR 6-10]), compared to those requiring the addition of plasma exchange suggesting more severe disease (median=12 days [IQR 8-22]). The overall mortality in the 10-year period was 38.9%, with 10.8% of the surviving patients relapsing after a median of 169 days (IQR 146-281) following the initial TTP event. There were no significant differences in remission status, time to remission, mortality or relapse by HIV status. All HIV positive patients who relapsed had defaulted their antiretroviral therapy (ART). Conclusion: HIV status did not affect patient outcomes in our cohort. ART is important in preventing HIV-associated TTP and relapse. What this study adds: A well-defined demographic of patients with TTP in the ART era in South Africa. Key words: Thrombotic thrombocytopenic purpura, haemolytic anaemia, thrombotic microangiopathy, HIV-associated TTP, ADAMTS13, treatment outcomes, plasma infusion, plasma exchange.
dc.identifier.apacitationVundla, N. (2024). <i>Trends in clinical presentation and treatment outcomes in a South African TTP cohort</i>. (). ,Faculty of Health Sciences ,Department of Medicine. Retrieved from http://hdl.handle.net/11427/40669en_ZA
dc.identifier.chicagocitationVundla, Nokubonga. <i>"Trends in clinical presentation and treatment outcomes in a South African TTP cohort."</i> ., ,Faculty of Health Sciences ,Department of Medicine, 2024. http://hdl.handle.net/11427/40669en_ZA
dc.identifier.citationVundla, N. 2024. Trends in clinical presentation and treatment outcomes in a South African TTP cohort. . ,Faculty of Health Sciences ,Department of Medicine. http://hdl.handle.net/11427/40669en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - Vundla, Nokubonga AB - Background: HIV is the most common cause of secondary thrombotic thrombocytopenic purpura (TTP) in South Africa. Objectives: To assess the clinical presentations and outcomes of patients treated for HIV-associated and idiopathic TTP. Methods: We conducted a retrospective cohort study of patients consecutively diagnosed with TTP from 2010 to 2020 at Groote Schuur Hospital. Study participants were identified by reviewing patient files and Western Cape Blood Services records. Kaplan-Meier curves and log-rank tests were used to evaluate remission rates overall and, by HIV status and treatment group. Logistic regression models were used to identify predictors of remission and relapse. Results: 139 patients were included, 85.6% of whom were HIV positive. There were no significant differences in the TTP pentad features by HIV status. Most patients achieved remission (71.9%) with an overall median time of 8 days. Remission occurred significantly earlier in those treated with FFPs only, suggesting less severe disease (median=8 days [IQR 6-10]), compared to those requiring the addition of plasma exchange suggesting more severe disease (median=12 days [IQR 8-22]). The overall mortality in the 10-year period was 38.9%, with 10.8% of the surviving patients relapsing after a median of 169 days (IQR 146-281) following the initial TTP event. There were no significant differences in remission status, time to remission, mortality or relapse by HIV status. All HIV positive patients who relapsed had defaulted their antiretroviral therapy (ART). Conclusion: HIV status did not affect patient outcomes in our cohort. ART is important in preventing HIV-associated TTP and relapse. What this study adds: A well-defined demographic of patients with TTP in the ART era in South Africa. Key words: Thrombotic thrombocytopenic purpura, haemolytic anaemia, thrombotic microangiopathy, HIV-associated TTP, ADAMTS13, treatment outcomes, plasma infusion, plasma exchange. DA - 2024 DB - OpenUCT DP - University of Cape Town KW - Medicine LK - https://open.uct.ac.za PY - 2024 T1 - Trends in clinical presentation and treatment outcomes in a South African TTP cohort TI - Trends in clinical presentation and treatment outcomes in a South African TTP cohort UR - http://hdl.handle.net/11427/40669 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/40669
dc.identifier.vancouvercitationVundla N. Trends in clinical presentation and treatment outcomes in a South African TTP cohort. []. ,Faculty of Health Sciences ,Department of Medicine, 2024 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/40669en_ZA
dc.language.rfc3066Eng
dc.publisher.departmentDepartment of Medicine
dc.publisher.facultyFaculty of Health Sciences
dc.subjectMedicine
dc.titleTrends in clinical presentation and treatment outcomes in a South African TTP cohort
dc.typeThesis / Dissertation
dc.type.qualificationlevelMasters
dc.type.qualificationlevelMMed
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
thesis_hsf_2024_vundla nokubonga.pdf
Size:
1.26 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections